GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
Clinical trial NCT05419362 · COMPLETED
Trial details
- NCT number
- NCT05419362
- Sponsor
- Genome & Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-07
- Primary completion
- 2024-08-26
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.